CP1 0.00% 17.0¢ cannpal animal therapeutics limited

Graph, page-25

  1. 1,376 Posts.
    lightbulb Created with Sketch. 448
    Love what ZLD is doing, but CP1 is way behind CPH so it's a tough sell for investors even though the concept of MC for dogs is a great idea. Easier approval processes, known and proven effects, huge market...

    It's just that if you have any CPH, I'm not sure this is a buy.
 
watchlist Created with Sketch. Add CP1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.